Knowledge Generation with Rule Induction in Cancer Omics

Abstract

The explosion of omics data availability in cancer research has boosted the knowledge of the molecular basis of cancer, although the strategies for its definitive resolution are still not well established. The complexity of cancer biology, given by the high heterogeneity of cancer cells, leads to the development of pharmacoresistance for many patients, hampering the efficacy of therapeutic approaches. Machine learning techniques have been implemented to extract knowledge from cancer omics data in order to address fundamental issues in cancer research, as well as the classification of clinically relevant sub-groups of patients and for the identification of biomarkers for disease risk and prognosis. Rule induction algorithms are a group of pattern discovery approaches that represents discovered relationships in the form of human readable associative rules. The application of such techniques to the modern plethora of collected cancer omics data can effectively boost our understanding of cancer-related mechanisms. In fact, the capability of these methods to extract a huge amount of human readable knowledge will eventually help to uncover unknown relationships between molecular attributes and the malignant phenotype. In this review, we describe applications and strategies for the usage of rule induction approaches in cancer omics data analysis. In particular, we explore the canonical applications and the future challenges and opportunities posed by multi-omics integration problems.

New diagnostic molecular markers and biomarkers in odontogenic tumors

“…For example, protein plays a regulatory role during cell function and because of dynamic protein interaction in a complex, proteomics-based technology provides identification and quantification of proteome. So it will be applicable in diagnostic approaches in addition to prognosis and therapeutic to vaccine development [ 26 ]. In odontogenic tumors, proteomics emerged significant alternation of protein levels in some classified types.…”

Multiplex protein analysis and ensemble machine learning methods of fine needle aspirates from prostate cancer patients reveal potential diagnostic signatures associated with tumour grade

“…Due to a rather limited patient cohort, we therefore explored a palette of ML methods for data analysis. By an ensemble approach, ie, protein signatures that repeatedly showed predictive value, we were able to obtain a functional network analysis relevant for both diagnostics and prediction of molecular determinants coupled to what is assumed to be needed for the efficacy of therapy 19,20 . This ensemble approach per se may be very valuable for multiplex analysis of limited clinical cohorts to indicate if further collection of a larger validation cohort has the potential to be cost effective.…”